#ÀÎõ¸¸¼º½ÀÁø, #ÀÎõ¸¸¼º½ÀÁøÇÑÀÇ¿ø, #¸¸¼º½ÀÁø, #ÀÎõ¸¸¼º½ÀÁø, #¸¸¼º½ÀÁøÇÑÀÇ¿ø, #¸¸¼º½ÀÁøÇÑÀÇ¿ø, #ÀÎõ¸¸¼º½ÀÁø, #¼Ûµµ¸¸¼º½ÀÁø
ÀÎõ¸¸¼º½ÀÁø,,ÀÎõ¸¸¼º½ÀÁøÇÑÀÇ¿ø,,¸¸¼º½ÀÁø,,ÀÎõ¸¸¼º½ÀÁø,,¸¸¼º½ÀÁøÇÑÀÇ¿ø,,¸¸¼º½ÀÁøÇÑÀÇ¿ø,,ÀÎõ¸¸¼º½ÀÁø,,¼Ûµµ¸¸¼º½ÀÁø
¾È³çÇϼ¼¿ä. ÀÎõ¸¸¼º½ÀÁø ¼Ûµµ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä
ÀÎõ¸¸¼º½ÀÁø ¼Ûµµ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â¸¸¼º½ÀÁø, ½ÀÁøÇǺΰú, ÈÆó»óÇǺο°, ¾ó±¼ÈÆó»ó½ÀÁø, ÈÆó½ÀÁø, ¾Æ±â¼Õ°¡¶ô½ÀÁø, ÈÆó»ó½ÀÁø, ½ÀÁø°¡·Á¿ò, ¼Õ°¡¶ô½ÀÁø, ¾Æ±âÇǺνÀÁø, ÁֺνÀÁø, ÈÆó»ó½ÀÁøÇǺΰú, ¹ß°¡¶ô½ÀÁø, ¹ß½ÀÁø, ½ÀÁø, ¿©¸§½ÀÁø, ¼Õ½ÀÁø, ½ÀÁøÄ¡·á, ´Ù¸®½ÀÁø, À¯µÎ½ÀÁø, ½ÀÁøÇÑÀÇ¿ø, »çŸ±¸´Ï½ÀÁø, ÇǺνÀÁø, Àü½Å½ÀÁø, ¹ß°¡¶ô»çÀ̽ÀÁøµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.
¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ICT, ÁÂÈÆ¿ä¹ý, ±Ý¿¬Ä§, Áõ·ùÇѾà, µµÀο¿ä¹ý, Àδë°È¿îµ¿, ÀåħÀü±âÀڱؼú, traction, ¼ºÀåºÎÁø¿µ¾ç±³À°, ºÀ¾àħ, ¿äÃß°ßÀÎÄ¡·á, ÁßdzÁ¶±â°ËÁø, ÇÁ·Ñ·ÎÅ׶óÇÇ, »öä¿ä¹ý, ¿äõÃßÃß³ª, Ç¥Àç¿Ä¡·á, ü¿Áø´Ü(Àü½Å), ½ÉºÎ¿Ä¡·á, ü¿Áø´Ü(ºÎºÐ), ±ÝÁÖħ, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù
¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼ Áø·áÁßÀÌ¸ç °æ±â ¾çÁֽà °í¾Ïµ¿, °æºÏ Ä¥°î±º ±â»ê¸é, ºÎ»ê ±ÝÁ¤±¸ ¼1µ¿, ÀÎõ ³²µ¿±¸ ±¸¿ù4µ¿, Àü³² À强±º »ï°è¸é, Àü³² À强±º Áø¿ø¸é, Àü³² ³ªÁֽà ´Ù½Ã¸é, ºÎ»ê °¼±¸ »ý°îµ¿, °¿ø ¼ÓÃʽà ´ëÆ÷µ¿, ÀÎõ ³²µ¿±¸ ¸¸¼ö5µ¿, ÀüºÏ ÀӽDZº °Áø¸é, Àü³² Çس²±º È¿ø¸é, ÀÎõ Áß±¸ °üµ¿1°¡, °æ±â ½ÃÈï½Ã Á¤¿Õ3µ¿, °¿ø °¸ª½Ã »çõ¸é, °æ±â ¿ëÀνà óÀα¸ ¿ø»ï¸é, °¿ø Æòⱺ ´ë°ü·É¸é, °æºÏ °æ»ê½Ã »ïdzµ¿, °¿ø Ⱦ¼º±º ¼¿ø¸é, ÀÎõ ¿¬¼ö±¸ ¼Ûµµ2µ¿, Àü³² ¿µ±¤±º È«³óÀ¾, ºÎ»ê Áß±¸ ³²Æ÷µ¿6°¡, °æ³² ÁøÁֽà »ó´ë2µ¿, Àü³² ´ã¾ç±º ¹«Á¤¸é, °æ³² â¿ø½Ã ¼º»ê±¸ Åä¿ùµ¿, °æ±â ºÎõ½Ã ¼Ò»ç±¸ ½É°îº»1µ¿, °æºÏ ±èõ½Ã °³·É¸é, ºÎ»ê ¿µµµ±¸ ºÀ·¡µ¿4°¡, °æ±â µ¿µÎõ½Ã °É»êµ¿, °æºÏ ¿¹Ãµ±º dz¾ç¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼ ³»¿øÇÏ°í °è½Ê´Ï´Ù
ÀÎõ¸¸¼º½ÀÁøÄ¡·á ãÀ¸½Ã´Â ¼Ûµµ½Åµµ½Ã, ÀÎõ³íÇöµ¿, ¹è°ð½Åµµ½Ã, °Ë¾Ï, ºÎõ, ¿î³²µ¿, µ¿ÀÎõ, ÀÎõ¼±¸, ¹è°ð, ÀÎõÁÖ¾È, ¿µÁ¾µµ, ºÀ´ãÀ¾, ¼þÀǵ¿, ¸¶µµ¸é, ¼Û¿ùµ¿, Á־ȵ¿, Áßµ¿, ¿¬¼öµ¿, ¿µÈïµµ, °Ë´Ü, ³²¾çÀ¾, °¡Á¤µ¿, ¿¬Èñµ¿, û¶ó, ½ÃÈï, °è¾ç±¸, ÆÈź¸é, ¿µÁ¾Çϴõµ½Ã, ¼Û¸²µ¿, ûÇе¿, ¼Ò·¡Æ÷±¸, »óµ¿, ³²±¸, ¼Ã¢µ¿, ¿Á·Ãµ¿ µî ÀÎõ Áö¿ª Áֹε鲲¼ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.
´õ »ìÆ캸±â
1. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 2018; 32:657.
2. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014; 70:338.
3. Camargo CA Jr, Ganmaa D, Sidbury R, et al. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J Allergy Clin Immunol 2014; 134:831.
4. Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics 2008; 122:812.
5. Ersser SJ, Cowdell F, Latter S, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev 2014; :CD004054.
6. Vender RB. Alternative treatments for atopic dermatitis: a selected review. Skin Therapy Lett 2002; 7:1.
7. van Gool CJ, Zeegers MP, Thijs C. Oral essential fatty acid supplementation in atopic dermatitis-a meta-analysis of placebo-controlled trials. Br J Dermatol 2004; 150:728.
8. Simpson EL, Flohr C, Eichenfield LF, et al. Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE). J Am Acad Dermatol 2018; 78:863.
9.
www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/207695Orig1s000ltr.pdf (Accessed on December 20, 2016).